🇺🇸 FDA
Pipeline program

A study to learn about the safety of BAY 3283142 in people with mild to moderate high blood pressure

22723

Phase 1 other active

Quick answer

A study to learn about the safety of BAY 3283142 in people with mild to moderate high blood pressure for Chronic kidney disease is a Phase 1 program (other) at Bayer AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Bayer AG
Indication
Chronic kidney disease
Phase
Phase 1
Modality
other
Status
active

Clinical trials